When: Sustained hold above $143 with volume confirmation

Then: Add remaining 50% of staged allocation

When: Weekly close below $134 on volume >15M shares

Then: Exit entire position immediately

HOLD

• Entry at $147.00 is now a 4.2% unrealized loss; market has confirmed this level as resistance
• 1.03x FCF coverage is razor-thin with $42.96B net debt and 2.4x net leverage providing no buffer if FCF drops 5%
• Q2 2026 net income of $2.98B is distorted by lapping a $1.86B impairment from Q2 2025 ($1.263B), not organic earnings power
• GLP-1 impact is a multi-year secular trend visible in reported NA demand weakness, not refuted by one quarter's accounting noise
• Current 15.7x forward P/E vs. historical 17-22x range means mean reversion could compress to 13-14x rather than expand
• PEP below 200 SMA for entire post-March period signals long-term downtrend per institutional standards
• MACD has been whipsawing for months; one positive crossover at zero is possibility, not confirmation of new trend
• CELH M&A scenario is speculative requiring board approval, regulatory clearance, and integration risk acceptance
• Alvalle gazpacho is niche product in small U.S. market segment; Buccaneers deal is sponsorship, not revenue catalyst
• Worst case retest to $131-$133 represents 5.5%-7% drawdown from $140.79, not 'small loss on technical break'
• Aggressive case requires multiple concurrent tailwinds: multiple expansion, operational inflection, GLP-1 narrative-only, benign macro
• Conservative case only requires one deterioration to justify waiting—superior asymmetry

→ vs aggressive: Entry at $147 with 4.2% loss and missed move from $147 to $134.95; market has rejected this level as resistance and doubling down confirms a bad decision

→ vs aggressive: 1.03x FCF coverage is not 'by design' discipline but structural fragility; a 5% FCF drop forces dividend cut, buyback pause, or more debt—all catastrophic for a 4.21% yield thesis

→ vs aggressive: Q2 2026 earnings growth is accounting artifact from impairment comparison, not organic performance; underlying volumes remain soft per Zacks and Barron's

→ vs aggressive: Mean reversion works both directions; multiple could compress to 13-14x if GLP-1 accelerates, KO gap widens, or recession hits despite 8% probability

→ vs aggressive: 200 SMA is institutional standard for trend identification; below it for post-March period is signal, not noise

→ vs aggressive: CELH M&A, Alvalle, and Buccaneers sponsorship are narrative catalysts, not fundamentals drivers for a $192B market cap company

→ vs aggressive: HOLD with defined re-entry triggers (50 SMA reversal at $140.13, MACD above +0.5, price below $138) is disciplined risk management, not passive inaction

→ vs aggressive: Worst case is not stop-out at $138 but continued grind to $131-$133 (5.5%-7% drawdown) if multiple factors deteriorate; not a 'small loss'

HOLD with defined re-entry triggers (sustained reclaim of 50 SMA at $1.40.13, MACD histogram expansion above +0.5), plus staged position sizing (50% on initial trigger, 50% on sustained hold above $1.43) and pre-committed exit plan if price breaks $1.34

• Hold with defined re-entry triggers is the correct synthesis between aggressive and conservative extremes
• Original entry at $1.47 is a sunk cost and should not anchor forward decision-making
• Q2 2025 EPS surge was artificially boosted by $1.5B impairment charge; organic earnings growth is more muted than headline suggests
• FCF coverage at 1.03x with $43B net debt and 2.4x leverage creates genuine structural fragility with no buffer for soft years
• Technicals are constructive: MACD histogram crossover at zero, RSI bullish divergence vs July 23 low, basing pattern at lower Bollinger band
• Re-entry triggers are technically correct but position sizing must be explicitly defined
• Dividend yield creates psychological trap that can lead to holding through drawdowns—pre-committed exit plan is essential
• Staged approach recommended: 50% add on initial trigger confirmation, remaining 50% only on sustained hold above $1.43
• Macro backdrop supportive: 8% recession probability, 85% no-cut regime, stable Fed
• 200 SMA should be used as confirmation tool, not dismissed as lagging indicator

→ vs aggressive: Celebrating Q2 EPS surge as evidence bear thesis is dead ignores the $1.5B impairment charge that artificially depressed Q2 2025 base; organic earnings power is much more muted than headline suggests

→ vs aggressive: Dismissal of 200 SMA as lagging indicator is institutional-discipline-blind framing that gets traders whipsawed at worst moments; lagging indicators are confirmation tools, not prediction tools

→ vs aggressive: Rebuttal of 1.03x FCF coverage as 'mature staples feature' is the weakest part of the argument; does not engage with what happens if FCF compresses 5-10% in stress scenario with $43B net debt

→ vs conservative: Original entry price at $1.47 is a sunk cost and anchoring bias; the analytical question is whether adding at $1.40 is a good idea based on current conditions, not whether $1.47 was a mistake

→ vs conservative: Overweighting the original entry price biases the entire analysis and makes the recommendation more cautious than the data warrants